| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Pharmaceuticals (Health Care sector), TSNDF's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.00M | $545.0K | - | |
| Other | 325.0K | $177.1K | - | |
| Dir | 1.0K | $545.00 | - | |
| CEO | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2023 | Jw Asset Management, LLC61 | Executive Chairman | Buy | 5,000 | $2.10 | $10,500.00 | - | |
| Sep 12, 2023 | Jw Asset Management, LLC61 | Executive Chairman | Buy | 15,000 | $2.11 | $31,603.50 | - | |
| Sep 11, 2023 | Jw Asset Management, LLC61 | Executive Chairman | Buy | 100,000 | $2.22 | $221,600.00 | +0.1% | |
| Sep 8, 2023 | Jw Asset Management, LLC61 | Executive Chairman | Buy | 25,000 | $2.19 | $54,867.50 | - | |
| Sep 6, 2023 | Jw Asset Management, LLC61 | Executive Chairman | Buy | 50,000 | $2.15 | $107,315.00 | - | |
| Sep 5, 2023 | Jw Asset Management, LLC61 | Executive Chairman | Buy | 100,000 | $2.19 | $219,320.00 | +0.1% | |
| Jun 28, 2023 | Jw Asset Management, LLC61 | Director, 10% Owner | Buy | 800,002 | $1.50 | $1,200,003.00 | +0.9% | |
| Jun 23, 2023 | Stauffer Keith | CFO | Buy | 700 | $0.00 | - | New | |
| Mar 30, 2023 | Swartzman Lisa | Director | Sell | 2,423 | $1.51 | $3,658.73 | -1.5% | |
| Mar 29, 2023 | Ghanem Ziad | President And COO | Buy | 12,600 | $1.52 | $19,152.00 | +18.4% |